Correction
Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
-
Correspondence: Graham A Colditz colditzg@wustl.edu
Alvin J Siteman Cancer Center and Department of Surgery, Washington University School of Medicine, Campus Box 8100 660 S Euclid Avenue, St Louis, MO 63110, USA
Breast Cancer Research 2007, 9:401 doi:10.1186/bcr1786
Published: 15 November 2007First paragraph (this article has no abstract)
Due to an oversight, the author of the above article [1] was incorrectly listed as having no competing interests. The competing interests section of this article should have read: